<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="ppub"/></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS155935</article-id><article-id pub-id-type="doi">10.1101/2022.10.16.512395</article-id><article-id pub-id-type="archive">PPR559277</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group><subj-group subj-group-type="europepmc-category"><subject>Covid-19</subject></subj-group></article-categories><title-group><article-title>Host independent deletion hotspots in the SARS-CoV-2 genome</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Khalid</surname><given-names>Mohammad</given-names></name><aff id="A1">Department of Pharmaceutics, College of Pharmacy, King Khalid University, Asir-Abha 61421, Saudi Arabia</aff><xref ref-type="corresp" rid="CR1">#</xref></contrib></contrib-group><author-notes><corresp id="CR1"><label>#</label><bold>Corresponding author:</bold> Mohammad Khalid, Department of Pharmaceutics, College of Pharmacy, King Khalid University, Abha-61421, Asir, Saudi Arabia. <email>mmabood@kku.edu.sa</email>, <email>1khalidmd@gmail.com</email>; Tel.: +966172417314</corresp></author-notes><pub-date pub-type="nihms-submitted"><day>20</day><month>10</month><year>2022</year></pub-date><pub-date pub-type="preprint"><day>17</day><month>10</month><year>2022</year></pub-date><permissions><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND 4.0 International license</ext-link>.</license-p></license><license><ali:license_ref>https://europepmc.org/downloads/openaccess</ali:license_ref><license-p>This preprint is made available via the <ext-link ext-link-type="uri" xlink:href="https://europepmc.org/downloads/openaccess">Europe PMC open access subset</ext-link>, for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original preprint source.</license-p></license></permissions><abstract><p id="P1">SARS-CoV-2 infects a wide range of hosts in varying degrees. The RNA genome of SARS-CoV-2 makes it prone to mutations. Advantageous mutations help the virus to evolve and the virus maintains such mutations across species. Here in this study, all non-human hosts-derived SARS-CoV-2 genomic sequences from the GISAID database were analyzed, and identified several deletion hotspots, which are maintained by the virus, across various host species, indicating their important role in the virus evolution. Several of these deletion hotspots are also found in human-derived SARS-CoV-2 genomic sequences. These deletion hotspots have the potential to affect the pathogenicity and virulence of the virus and have a role in molecular and serological diagnostics. Potentially, they can lead to immune escape, resulting in vaccine failure and drug-resistant variants.</p></abstract><kwd-group><kwd>Deletion</kwd><kwd>SARS-CoV-2</kwd><kwd>Hotspot</kwd><kwd>Zoonosis</kwd><kwd>Variant of Concern (VOC)</kwd></kwd-group></article-meta></front><body><sec id="S1" sec-type="intro"><title>Introduction</title><p id="P2">In December 2019, an outbreak of SARS-CoV-2 led to COVID-19 pandemic, which caused unprecedented damage on healthcare and socio-economic fronts. The virus is transmitted to human by zoonotic spillover (<xref ref-type="bibr" rid="R1">1</xref>) may be from bat (<xref ref-type="bibr" rid="R2">2</xref>) or pangolin (<xref ref-type="bibr" rid="R3">3</xref>). The virus uses Spike protein to interact ACE-2 receptor on host cell surface to infect the cell (<xref ref-type="bibr" rid="R4">4</xref>–<xref ref-type="bibr" rid="R6">6</xref>). Molecular and serological techniques have been employed to detect the virus using nasopharyngeal samples.</p><p id="P3">The SARS-CoV-2 has a positive-sense single-stranded RNA (+ssRNA) genome of 29-30 Kb size (<xref ref-type="bibr" rid="R7">7</xref>). The RNA genome makes the virus more prone to mutations due to lack of proofreading function of RNA-dependent RNA polymerase (RdRp) (<xref ref-type="bibr" rid="R8">8</xref>). However, viruses from coronavirus family are known to have a proofreading mechanism (<xref ref-type="bibr" rid="R9">9</xref>, <xref ref-type="bibr" rid="R10">10</xref>) expecting to have low mutation rate, though, thousands of mutant variants of the virus have been emerged over the span of two years, infecting people across the globe (<xref ref-type="bibr" rid="R11">11</xref>). Some of these mutations are able to generate specific genetic lineages that have outcompeted the original virus (<xref ref-type="bibr" rid="R12">12</xref>). These lineages are characterized by higher transmission rate or virulence or reduced effectiveness of counter measures and classified by WHO as variants of concern (VOCs) (<xref ref-type="bibr" rid="R13">13</xref>).</p><p id="P4">Mutational instances occurring at same genomic locations in variety of hosts are mutational hotspots, potentially, they make viral evolution incredibly repeatable across the hosts. SARS-CoV-2 could evolve along these hotspots, driving its evolution to make the virus more efficient in transmissibility and virulence (<xref ref-type="bibr" rid="R14">14</xref>, <xref ref-type="bibr" rid="R15">15</xref>) Furthermore, such hotspots might affect primer-binding and probe-binding to target sites, and neutralizing antibodies binding, which can reduce the sensitivity of molecular and serological diagnostic tests (<xref ref-type="bibr" rid="R16">16</xref>, <xref ref-type="bibr" rid="R17">17</xref>). Moreover, these mutations can cause vaccine failure and emergence of antiviral drug resistant viral variants.</p><p id="P5">Zoonotic spillover of the SARS-CoV-2 has motivated this study to analyze the SARS-CoV-2 genomic sequences, derived from non-human hosts to investigate common mutations in the viral genome and to identify deletion hotspots across the viral hosts.</p></sec><sec id="S2" sec-type="methods"><title>Methods</title><sec id="S3"><title>SARS-CoV-2 genome sequences derived from non-human hosts</title><p id="P6">In this study, all 2,162 available full-length SARS-CoV-2 genome sequences derived from non-human hosts obtained from the GISAID database (<xref ref-type="bibr" rid="R11">11</xref>) as of 27<sup>th</sup> August 2022 were analyzed. These SARS-CoV-2 genomic sequences were derived from all non-human hosts across the globe viz; mink, deer, cat, dog, lion, tiger, hamster, mouse, bat, gorilla, pangolin snow leopard, otter and monkey.</p></sec><sec id="S4"><title>Analysis of deletion mutations in non-human hosts derived SARS-CoV-2 genome</title><p id="P7">The FASTA format file of the SARS-CoV-2 genome sequences were downloaded from GISAID database and analyzed using online tools Nextclade of Nextstrain (<xref ref-type="bibr" rid="R18">18</xref>–<xref ref-type="bibr" rid="R21">21</xref>). Nextclade uses SARS-CoV-2 Wuhan-Hu-1/2019 (Accession # MN908947) isolate as a reference genome. The Algorithm was Sequence alignment, Translation, Mutation calling, Detection of PCR primer changes, Phylogenetic placement, Clade assignment and Quality Control. The data were compiled and presented using Microsoft Excel 2019.</p><p id="P8">Every deletion in nucleotide sequences from reference strain, considered as a mutation if the deletion happened more than one instance in the genome.</p></sec><sec id="S5"><title>Phylogenetic analysis of non-human derived SARS-CoV-2</title><p id="P9">The phylogenetic tree was generated by NextStrain Auspice (<xref ref-type="bibr" rid="R18">18</xref>). The phylogenetic tree was visualized from NexStrain inferred evolutionary relationships between different viral genomes derived from non-human hosts, based on their genomic sequences.</p></sec></sec><sec id="S6" sec-type="results"><title>Results</title><sec id="S7"><title>Hosts and their number of genomic sequences</title><p id="P10">The details of the SARS-CoV-2 genome sequences derived from all non-human hosts and submitted to GISAID database (<xref ref-type="bibr" rid="R11">11</xref>). The viral sequences were available as on 27 August 2022. Mink (<italic>Neovison vison</italic>) seems to be susceptible to the infection and has second highest number of genomic sequences derived from it, as shown in the <xref ref-type="table" rid="T1">Table 1</xref>.</p></sec><sec id="S8"><title>Phylogenetic tree of non-human derived SARS-CoV-2</title><p id="P11">Phylogenetic tree generated with NextStrain analysis tool using non-human hosts derived genomic sequences from the GISAID database, as shown in <xref ref-type="fig" rid="F1">Figure 1</xref>. The figure also revealed clad information of these genomic sequences.</p><p id="P12">Bat and pangolin derived genomic sequences excluded from the phylogenetic analysis because they behaved very differently; placing themselves far away from the rest of the genomic sequences and that hid details of the remaining samples.</p></sec><sec id="S9"><title>Deletion mutations in non-human derived SARS-CoV-2</title><p id="P13">During the analysis of 2,162 full-length SARS-CoV-2 genome sequences, in this study 187 deletion mutations have been found across all the non-human hosts (<xref ref-type="supplementary-material" rid="SD1">Supplementary Table 1</xref>). Out of 2162 samples, 4 samples were derived from monkey (<xref ref-type="table" rid="T1">Table 1</xref>) but none of these 4 samples have deletion when compared to reference genome (Accession # MN908947). Mouse derived genomic sequences contributed 23 samples and contain many deletions but they were single instances so discarded because of the study criteria, only one deletion mutation (26260-26283) was found in mouse derived samples and that was unique to mouse only (<xref ref-type="supplementary-material" rid="SD1">Supplementary Table 1</xref>). Bat and pangolin derived genomic sequences had many deletion mutations (73 and 35 respectively) and most of them are unique to either bat or pangolin only (<xref ref-type="supplementary-material" rid="SD1">Supplementary Table 1</xref>).</p></sec><sec id="S10"><title>Identification of deletion hotspots across the hosts</title><p id="P14"><xref ref-type="supplementary-material" rid="SD1">Supplementary Table 1</xref> revealed many deletion mutations are common across the hosts in various ORFs. These 10 common deletion locations are the hotspot of deletion mutations viz; 516-518, 6506-6508, 6513-6515 and 11288-11296 are laying in ORF1a, while 21765-21770, 21992-21994, and 22029-22034 are placed in Spike gene and 28248-28253, are laying in ORF-8, 28271 is in between ORF-8 and N, and 28362-28370 in ORF-N. It is very less likely that these hosts were infected by the common variants of the virus, because the genomic sequences were collected from these hosts at various different time point as well as from different geographical locations. These 10 deletion hotspots were analyzed for the occurrence in every host, <xref ref-type="fig" rid="F2">Figure 2</xref>. From these 10 deletion hotspots, 6 are found in majority of the hosts in high percentage, these deletion hotspots are 11288-11296, 21765-21770, 21992-21994, 22029-22034, 28248-28253, and 28271.</p></sec><sec id="S11"><title>List of identified deletion hotspots and position in ORFs: <xref ref-type="table" rid="T2">Table 2</xref></title><p id="P15">The 10 deletion hotspots; 516-518, 6506-6508, 6513-6515 and 11288-11296 are laying in ORF1a, while 21765-21770, 21992-21994, and 22029-22034 are placed in Spike gene and 28248-28253, are laying in ORF-8 and 28271, and 28362-28370 in ORF-N, are shown in <xref ref-type="fig" rid="F3">Figure 3</xref> (not on scale) and amino acid truncation are also listed, Table 3.</p></sec></sec><sec id="S12" sec-type="discussion"><title>Discussions</title><p id="P16">The spike protein of SARS-CoV-2 interacts with the ACE-2 receptor in the host’s cell. The interaction of the spike protein with the ACE-2 makes a cell prone to the virus infection (<xref ref-type="bibr" rid="R4">4</xref>–<xref ref-type="bibr" rid="R6">6</xref>). Spike protein interacts with ACE-2 from various species, allowing the virus to cross species barriers, as shown in <xref ref-type="table" rid="T1">Table 1</xref>, the SARS-CoV-2 is capable of infecting a wide range of mammalian hosts. Mink (<italic>Neovison vison</italic>) derived virus genomic sequence is second highest, only to that of humans, and the virus has been found to cause viral pneumonia in the mink (<xref ref-type="bibr" rid="R22">22</xref>, <xref ref-type="bibr" rid="R23">23</xref>). The SARS-CoV-2 isolates derived from mink and humans also found to have several common mutations (<xref ref-type="bibr" rid="R24">24</xref>).</p><p id="P17">The SARS-CoV-2 outbreak is a zoonotic spillover suspected to be from bat or pangolin (<xref ref-type="bibr" rid="R1">1</xref>–<xref ref-type="bibr" rid="R3">3</xref>). All 2162, non-human derived SARS-COV-2 genomic sequences were analyzed for genomic similarities with reference to Wuhan-Hu-1/2019 (Accession # MN908947) isolate. The bat and pangolin derived SARS-COV-2 genomic sequences were not closely related, as a result, phylogenetic tree overlooked the information about the remaining genomic sequences (data not shown), and so the bat and pangolin derived SARS-COV-2 genomic sequences were excluded from the phylogenetic analysis (<xref ref-type="fig" rid="F1">Figure 1</xref>).</p><p id="P18">The non-human derived genomic sequences belong to variety of clads but majority of these samples were from clad 20A, B, C, E and 21J (Delta), suggesting variety of clades of SARS-CoV-2 was transmitted to variety of non-human hosts, <xref ref-type="fig" rid="F1">Figure 1</xref>.</p><p id="P19">The SARS-CoV-2 genome is very plastic to accommodate variety of mutations; from the 2162 genome sequence analysis revealed 187 deletion mutations (<xref ref-type="supplementary-material" rid="SD1">Supplementary Table 1</xref>). Several of them are unique to specific hosts; the SARS-CoV-2 genomic sequences derived from bats contained the highest number of deletion mutations (73), most of them were unique to bat derived samples only, suggesting non-advantageous deletions. While many other mutations were found across the mammalian species and considered deletion hotspots in this study, 10 of them are worth mentioning viz; 516-518 is a deletion in NSP1 at position M85Δ, found in mink, deer and cat derived SARS-CoV-2 genomic sequences, which was also reported to be in human-derived samples (<xref ref-type="bibr" rid="R25">25</xref>, <xref ref-type="bibr" rid="R27">27</xref>). Deletion 6506-6508 is translated to ORF1a T2081Δ, found in mink, deer and cat derived samples. Another ORF1a deletion, 6513-6515 is translated to S2083Δ found in this study in min, deer, cat and dog derived SARS-CoV-2, which was also reported in human-derived SARS-CoV-2 genomic sequences in Vanmechelen et. al., study (<xref ref-type="bibr" rid="R26">26</xref>). The deletion 11288-11296 in ORF1a: NSP6: SGF 3675–3677Δ found in this study, was also reported in human derived genomic sequences (<xref ref-type="bibr" rid="R27">27</xref>). While 21765-21770 deletion is in S: H69/V70Δ which was reported in human derived samples, causing increased viral transmission and infectivity and the virus variants was known as Omicron was also found in human derived samples and became one of the dominant variants across the globe (<xref ref-type="bibr" rid="R26">26</xref>, <xref ref-type="bibr" rid="R27">27</xref>, <xref ref-type="bibr" rid="R28">28</xref>). The 21992-21994 and 22029-22034 deletions reported in this study in majority of hosts derived genomic sequences, were also reported in human-derived SARS-CoV-2 genome sequences in non-RBD S1 region and known to have role in viral transmission and infectivity (<xref ref-type="bibr" rid="R27">27</xref>, <xref ref-type="bibr" rid="R28">28</xref>). The deletion 28248-28253 translated as DF119-120Δ in ORF8 reported here, which was also found in human-derived SARS-CoV-2 genome sequences (<xref ref-type="bibr" rid="R27">27</xref>). The 28271 deletion is nucleotide deletion in non-coding region between ORF-8 and N reported in this study in most of the non-human host derived SARS-CoV-2, was also found in human derived samples (<xref ref-type="bibr" rid="R26">26</xref>, <xref ref-type="bibr" rid="R27">27</xref>), and 28362-28370 is deletion in N: ENA27-29Δ was also reported to be found in human-derived SARS-CoV-2 genome sequences (<xref ref-type="bibr" rid="R26">26</xref>).</p><p id="P20">This study reports 10 deletion hotspots in SARS-CoV-2 genome sequences, of those 7 hotspots were found in most of the hosts (<xref ref-type="supplementary-material" rid="SD1">Supplementary Table 1</xref> and <xref ref-type="fig" rid="F2">Figure 2</xref>) and also reported in human derived SARS-CoV-2 genome sequences in various studies. Many of these deletion hotspots have functional role in the virus pathogenicity and virulence.</p></sec><sec id="S13" sec-type="conclusions"><title>Conclusions</title><p id="P21">The SARS-CoV-2 has a modest rate of mutation, these mutations help the virus to evolve to counter hosts defenses. The virus conserves many of such deletion mutations at same genomic locations, irrespective of hosts. Such hotspots have potential to decrease the efficiency of molecular and serological diagnostic tests as well as failure of vaccines and antivirus drugs.</p></sec><sec id="S14"><title>Abbreviations</title><glossary><def-list><def-item><term>GISAID</term><def><p id="P22">Global initiative on sharing all influenza data</p></def></def-item><def-item><term>NSP</term><def><p id="P23">Non-structural protein</p></def></def-item><def-item><term>ORF-8</term><def><p id="P24">Open Reading Frame-8</p></def></def-item><def-item><term>UTRs</term><def><p id="P25">Untranslated regions</p></def></def-item></def-list></glossary></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>Supplementary Table 1</label><media xlink:href="EMS155935-supplement-Supplementary_Table_1.xlsx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="d5aAdGbB" position="anchor"/></supplementary-material></sec></body><back><ack id="S15"><title>Acknowledgement</title><p>I would like to extend my thanks to the people at NCBI database and GISAID for making the SARS-CoV-2 genome sequences available.</p><sec id="S16"><title>Funding</title><p>The author extends his appreciation to the Deanship of Scientific Research at King Khalid University for funding this work through Large Groups (Project under grant number RGP.2/244/43).</p></sec></ack><ref-list><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mori</surname><given-names>M</given-names></name><name><surname>Capasso</surname><given-names>C</given-names></name><name><surname>Carta</surname><given-names>F</given-names></name><name><surname>a Donald</surname><given-names>W</given-names></name><name><surname>Supuran</surname><given-names>CT</given-names></name></person-group><article-title>A deadly spillover: SARS-CoV-2 outbreak</article-title><source>Expert Opin Ther Pat</source><year>2020</year><volume>30</volume><fpage>481</fpage><lpage>485</lpage></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>M-Y</given-names></name><name><surname>Zhao</surname><given-names>R</given-names></name><name><surname>Gao</surname><given-names>L-J</given-names></name><name><surname>Gao</surname><given-names>X-F</given-names></name><name><surname>Wang</surname><given-names>D-P</given-names></name><name><surname>Cao</surname><given-names>J-M</given-names></name></person-group><article-title>SARS-CoV-2: structure, biology, and structure-based therapeutics development</article-title><source>Front Cell Infect Microbiol</source><year>2020</year><volume>10</volume><fpage>724</fpage><pub-id pub-id-type="doi">10.3389/fcimb.2020.587269</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lam</surname><given-names>TTY</given-names></name><name><surname>Jia</surname><given-names>N</given-names></name><name><surname>Zhang</surname><given-names>YW</given-names></name><etal/></person-group><article-title>Identifying SARS-CoV-2-related coronaviruses in Malayan pangolins</article-title><source>Nature</source><year>2020</year><volume>583</volume><fpage>282</fpage><lpage>285</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2169-0</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>L</given-names></name><name><surname>Niu</surname><given-names>S</given-names></name><name><surname>Song</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Lu</surname><given-names>G</given-names></name><name><surname>Qiao</surname><given-names>C</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Yuen</surname><given-names>KY</given-names></name><etal/></person-group><article-title>Structural and functional basis of SARS-CoV-2 entry by using human ACE2</article-title><source>Cell</source><year>2020</year><volume>181</volume><fpage>894</fpage><lpage>904</lpage></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lan</surname><given-names>J</given-names></name><name><surname>Ge</surname><given-names>J</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Shan</surname><given-names>S</given-names></name><name><surname>Zhou</surname><given-names>H</given-names></name><name><surname>Fan</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Shi</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><etal/></person-group><article-title>Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor</article-title><source>Nature</source><year>2020</year><volume>581</volume><fpage>215</fpage><lpage>220</lpage></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shang</surname><given-names>J</given-names></name><name><surname>Ye</surname><given-names>G</given-names></name><name><surname>Shi</surname><given-names>K</given-names></name><name><surname>Wan</surname><given-names>Y</given-names></name><name><surname>Luo</surname><given-names>C</given-names></name><name><surname>Aihara</surname><given-names>H</given-names></name><name><surname>Geng</surname><given-names>Q</given-names></name><name><surname>Auerbach</surname><given-names>A</given-names></name><name><surname>Li</surname><given-names>F</given-names></name></person-group><article-title>Structural basis of receptor recognition by SARS-CoV-2</article-title><source>Nature</source><year>2020</year><volume>581</volume><fpage>221</fpage><lpage>224</lpage></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>JFW</given-names></name><name><surname>Kok</surname><given-names>KH</given-names></name><name><surname>Zhu</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan</article-title><source>Emerg Microbes Infect</source><year>2020</year><volume>9</volume><issue>1</issue><fpage>221</fpage><lpage>36</lpage></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanjuán</surname><given-names>R</given-names></name><name><surname>Nebot</surname><given-names>MR</given-names></name><name><surname>Chirico</surname><given-names>N</given-names></name><name><surname>Mansky</surname><given-names>LM</given-names></name><name><surname>Belshaw</surname><given-names>R</given-names></name></person-group><article-title>Viral mutation rates</article-title><source>J Virol</source><year>2010</year><volume>84</volume><fpage>9733</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1128/JVI.00694-10</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peck</surname><given-names>KM</given-names></name><name><surname>Lauring</surname><given-names>AS</given-names></name></person-group><article-title>Complexities of Viral Mutation Rates</article-title><source>J Virol</source><year>2018</year><month>May</month><day>2</day><volume>92</volume><issue>14</issue></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robson</surname><given-names>F</given-names></name><name><surname>Khan</surname><given-names>KS</given-names></name><name><surname>Le</surname><given-names>TK</given-names></name><name><surname>Paris</surname><given-names>C</given-names></name><name><surname>Demirbag</surname><given-names>S</given-names></name><name><surname>Barfuss</surname><given-names>P</given-names></name><etal/></person-group><article-title>Coronavirus RNA. proofreading: molecular basis and therapeutic targeting</article-title><source>Mol Cell</source><year>2020</year><volume>79</volume><fpage>710</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2020.11.048</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="web"><collab>GISAID</collab><comment><ext-link ext-link-type="uri" xlink:href="https://www.gisaid.org">https://www.gisaid.org</ext-link></comment></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mullen</surname><given-names>JL</given-names></name><name><surname>Tsueng</surname><given-names>G</given-names></name><name><surname>Latif</surname><given-names>AA</given-names></name><name><surname>Alkuzweny</surname><given-names>M</given-names></name><name><surname>Cano</surname><given-names>M</given-names></name><name><surname>Haag</surname><given-names>E</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Zeller</surname><given-names>M</given-names></name><name><surname>Hufbauer</surname><given-names>E</given-names></name><name><surname>Matteson</surname><given-names>N</given-names></name><name><surname>Andersen</surname><given-names>KG</given-names></name><etal/></person-group><article-title>Center for Viral Systems Biology</article-title><source>outbreak info</source><year>2020</year><date-in-citation>Accessed 27 August 2022</date-in-citation><comment><ext-link ext-link-type="uri" xlink:href="https://outbreak.info">https://outbreak.info</ext-link></comment></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="web"><collab>World Health Organization</collab><source>Tracking SARS-CoV-2 variants</source><comment><ext-link ext-link-type="uri" xlink:href="https://www.who.int/en/activities/tracking-SARS-CoV-2-variants">https://www.who.int/en/activities/tracking-SARS-CoV-2-variants</ext-link>.</comment></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weber</surname><given-names>S</given-names></name><name><surname>Ramirez</surname><given-names>C</given-names></name><name><surname>Doerfler</surname><given-names>W</given-names></name></person-group><article-title>Signal hotspot mutations in SARS-CoV-2 genomes evolve as the virus spreads and actively replicates in different parts of the world</article-title><source>Virus Res</source><year>2020</year><volume>289</volume><elocation-id>198170</elocation-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korber</surname><given-names>B</given-names></name><name><surname>Fischer</surname><given-names>WM</given-names></name><name><surname>Gnanakaran</surname><given-names>S</given-names></name><etal/></person-group><article-title>Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus</article-title><source>Cell</source><year>2020</year><volume>20</volume><fpage>30820</fpage><lpage>25</lpage></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Álvarez-Díaz</surname><given-names>DA</given-names></name><name><surname>Franco-Muñoz</surname><given-names>C</given-names></name><name><surname>Laiton-Donato</surname><given-names>K</given-names></name><etal/></person-group><article-title>Molecular analysis of several in-house rRT-PCR protocols for SARS-CoV-2 detection in the context of genetic variability of the virus in Colombia</article-title><source>Infect Genet Evol</source><year>2020</year><volume>84</volume><elocation-id>104390</elocation-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lokman</surname><given-names>SM</given-names></name><name><surname>Rasheduzzaman</surname><given-names>M</given-names></name><name><surname>Salauddin</surname><given-names>A</given-names></name><etal/></person-group><article-title>Exploring the genomic and proteomic variations of SARS-CoV-2 spike glycoprotein: a computational biology approach</article-title><source>Infect Genet Evol</source><year>2020</year><volume>84</volume><elocation-id>104389</elocation-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="web"><date-in-citation>Accessed on 05/09/2022</date-in-citation><comment><ext-link ext-link-type="uri" xlink:href="https://clades.nextstrain.org/">https://clades.nextstrain.org/</ext-link></comment></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rambaut</surname><given-names>A</given-names></name><name><surname>Holmes</surname><given-names>EC</given-names></name><name><surname>O’Toole</surname><given-names>A</given-names></name><name><surname>Hill</surname><given-names>V</given-names></name><name><surname>McCrone</surname><given-names>JT</given-names></name><name><surname>Ruis</surname><given-names>C</given-names></name><name><surname>du Plessis</surname><given-names>L</given-names></name><name><surname>Pybus</surname><given-names>OG</given-names></name></person-group><article-title>A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology</article-title><source>Nat Microbiol</source><year>2020</year><volume>5</volume><fpage>1403</fpage><lpage>1407</lpage></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aksamentov</surname><given-names>I</given-names></name><name><surname>Roemer</surname><given-names>C</given-names></name><name><surname>Hodcroft</surname><given-names>EB</given-names></name><name><surname>Neher</surname><given-names>RA</given-names></name></person-group><article-title>Nextclade: clade assignment, mutation calling and quality control for viral genomes</article-title><year>2021</year></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmad</surname><given-names>Waqas</given-names></name><name><surname>Ahmad</surname><given-names>Sarfraz</given-names></name><name><surname>Basha</surname><given-names>Riyaz</given-names></name></person-group><article-title>Analysis of the mutation dynamics of SARS-CoV-2 genome in the samples from Georgia State of the United States</article-title><source>Gene</source><year>2022</year><volume>841</volume><elocation-id>146774</elocation-id><pub-id pub-id-type="doi">10.1016/j.gene.2022.146774</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oreshkova</surname><given-names>N</given-names></name><name><surname>Molenaar</surname><given-names>RJ</given-names></name><name><surname>Vreman</surname><given-names>S</given-names></name><name><surname>Harders</surname><given-names>F</given-names></name><name><surname>Munnink</surname><given-names>BBO</given-names></name><name><surname>Hakze-van der Honing</surname><given-names>RW</given-names></name><name><surname>Gerhards</surname><given-names>N</given-names></name><name><surname>Tolsma</surname><given-names>P</given-names></name><name><surname>Bouwstra</surname><given-names>R</given-names></name><name><surname>Sikkema</surname><given-names>RS</given-names></name><etal/></person-group><article-title>SARS-CoV-2 infection in farmed minks, the Netherlands, April and May 2020</article-title><source>Eurosurveillance</source><year>2020</year><volume>25</volume><elocation-id>2001005</elocation-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Enserink</surname><given-names>M</given-names></name></person-group><article-title>Coronavirus rips through Dutch mink farms, triggering culls</article-title><source>Science</source><year>2020</year><volume>368</volume><fpage>1169</fpage></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khalid</surname><given-names>M</given-names></name><name><surname>Alshishani</surname><given-names>A</given-names></name><name><surname>Al-ebini</surname><given-names>Y</given-names></name></person-group><article-title>Genome Similarities between Human-Derived and Mink-Derived SARS-CoV-2 Make Mink a Potential Reservoir of the Virus</article-title><source>Vaccines</source><year>2022</year><volume>10</volume><fpage>1352</fpage><pub-id pub-id-type="doi">10.3390/vaccines10081352</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>TT</given-names></name><name><surname>Pham</surname><given-names>TN</given-names></name><name><surname>Van</surname><given-names>TD</given-names></name><name><surname>Nguyen</surname><given-names>TT</given-names></name><name><surname>Nguyen</surname><given-names>DTN</given-names></name><name><surname>Le</surname><given-names>HNM</given-names></name><etal/></person-group><article-title>Genetic diversity of SARS-CoV-2 and clinical, epidemiological characteristics of COVID-19 patients in Hanoi, Vietnam</article-title><source>PLoS ONE</source><year>2020</year><volume>15</volume><issue>11</issue><elocation-id>e0242537</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0242537</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vanmechelen</surname><given-names>B</given-names></name><name><surname>Logist</surname><given-names>AS</given-names></name><name><surname>Wawina-Bokalanga</surname><given-names>T</given-names></name><name><surname>Verlinden</surname><given-names>J</given-names></name><name><surname>Martí-Carreras</surname><given-names>J</given-names></name><name><surname>Geenen</surname><given-names>C</given-names></name><name><surname>Slechten</surname><given-names>B</given-names></name><name><surname>Cuypers</surname><given-names>L</given-names></name><name><surname>André</surname><given-names>E</given-names></name><name><surname>Baele</surname><given-names>G</given-names></name><name><surname>Maes</surname><given-names>P</given-names></name></person-group><article-title>Identification of the First SARS-CoV-2 Lineage B.1.1.529 Virus Detected in Europe</article-title><source>Microbiol Resour Announc</source><year>2022</year><month>Feb</month><day>17</day><volume>11</volume><issue>2</issue><elocation-id>e0116121</elocation-id><comment>Epub 2022 Feb 3</comment><pub-id pub-id-type="pmid">35112910</pub-id><pub-id pub-id-type="pmcid">PMC8812313</pub-id><pub-id pub-id-type="doi">10.1128/mra.01161-21</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdullaev</surname><given-names>A</given-names></name><name><surname>Abdurakhimov</surname><given-names>A</given-names></name><name><surname>Mirakbarova</surname><given-names>Z</given-names></name><name><surname>Ibragimova</surname><given-names>S</given-names></name><name><surname>Tsoy</surname><given-names>V</given-names></name><name><surname>Nuriddinov</surname><given-names>S</given-names></name><name><surname>Dalimova</surname><given-names>D</given-names></name><name><surname>Turdikulova</surname><given-names>S</given-names></name><name><surname>Abdurakhmonov</surname><given-names>I</given-names></name></person-group><article-title>Genome sequence diversity of SARS-CoV-2 obtained from clinical samples in Uzbekistan</article-title><source>PLoS One</source><year>2022</year><month>Jun</month><day>27</day><volume>17</volume><issue>6</issue><elocation-id>e0270314</elocation-id><pub-id pub-id-type="pmid">35759503</pub-id><pub-id pub-id-type="pmcid">PMC9236271</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0270314</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papanikolaou</surname><given-names>V</given-names></name><name><surname>Chrysovergis</surname><given-names>A</given-names></name><name><surname>Ragos</surname><given-names>V</given-names></name><name><surname>Tsiambas</surname><given-names>E</given-names></name><name><surname>Katsinis</surname><given-names>S</given-names></name><name><surname>Manoli</surname><given-names>A</given-names></name><name><surname>Papouliakos</surname><given-names>S</given-names></name><name><surname>Roukas</surname><given-names>D</given-names></name><name><surname>Mastronikolis</surname><given-names>S</given-names></name><name><surname>Peschos</surname><given-names>D</given-names></name><name><surname>Batistatou</surname><given-names>A</given-names></name></person-group><article-title>From Delta to Omicron: S1-RBD/S2 mutation/deletion equilibrium in SARS-CoV-2 defined variants</article-title><source>Gene</source><year>2022</year><month>Jan</month><day>4</day><elocation-id>146134</elocation-id><pub-id pub-id-type="doi">10.1016/j.gene.2021.146134</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Figure 1</label><caption><title>Phylogenetic tree of the SARS-CoV-2 genomes, derived from various hosts</title><p>Phylogenetic tree of circulating of SARS-CoV-2 genomic sequences derived from non-human hosts. The phylogenetic tree was generated using the NextStrain Auspice online tools.</p></caption><graphic xlink:href="EMS155935-f001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><title>Deletions hotspots and their occurrence in various host</title><p>Identification of deletion hotspots in SARS-CoV-2 genome derived from non-human hosts. The analysis based on all SARS-CoV-2 genome sequences derived from non-human hosts, available on GISAID database as on 27/08/2022.</p></caption><graphic xlink:href="EMS155935-f002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><title>Deletion hotspots</title><p>Schematic diagram of SARS-CoV-2 genome with various ORFs. The black line representing deletion hotspots in the SARS-CoV-2 genome (not on scale).</p></caption><graphic xlink:href="EMS155935-f003"/></fig><table-wrap id="T1" position="float" orientation="portrait"><label>Table 1</label><caption><title>The SARS-CoV-2 infection in various hosts</title></caption><table frame="box" rules="all"><thead><tr><th align="left" valign="top">S. No.</th><th align="left" valign="top">Name</th><th align="center" valign="top">Sequences</th></tr></thead><tbody><tr><td align="left" valign="top">1</td><td align="left" valign="top">Human <italic>(Homo sapiens)</italic></td><td align="center" valign="top">12,590,689</td></tr><tr><td align="left" valign="top">2</td><td align="left" valign="top">Mink <italic>(Neovison vison)</italic></td><td align="center" valign="top">1,346</td></tr><tr><td align="left" valign="top">3</td><td align="left" valign="top">Deer <italic>(Odocoileus virginianus)</italic></td><td align="center" valign="top">332</td></tr><tr><td align="left" valign="top">4</td><td align="left" valign="top">Cat <italic>(Felis catus)</italic></td><td align="center" valign="top">121</td></tr><tr><td align="left" valign="top">5</td><td align="left" valign="top">Dog <italic>(Canis lupus familiaries)</italic></td><td align="center" valign="top">84</td></tr><tr><td align="left" valign="top">6</td><td align="left" valign="top">Lion <italic>(Panthera leo)</italic></td><td align="center" valign="top">75</td></tr><tr><td align="left" valign="top">7</td><td align="left" valign="top">Mink2 <italic>(Neogale vison)</italic></td><td align="center" valign="top">45</td></tr><tr><td align="left" valign="top">8</td><td align="left" valign="top">Tiger <italic>(Panthera tigris)</italic></td><td align="center" valign="top">42</td></tr><tr><td align="left" valign="top">9</td><td align="left" valign="top">Hamester <italic>(Mesocricetus auratus)</italic></td><td align="center" valign="top">30</td></tr><tr><td align="left" valign="top">10</td><td align="left" valign="top">Mouse <italic>(Mus musculus)</italic></td><td align="center" valign="top">23</td></tr><tr><td align="left" valign="top">11</td><td align="left" valign="top">Bat <italic>(Rhinolophus)</italic></td><td align="center" valign="top">15</td></tr><tr><td align="left" valign="top">12</td><td align="left" valign="top">Gorilla <italic>(Gorilla gorilla)</italic></td><td align="center" valign="top">15</td></tr><tr><td align="left" valign="top">13</td><td align="left" valign="top">Pangolin <italic>(Manis javanica)</italic></td><td align="center" valign="top">13</td></tr><tr><td align="left" valign="top">14</td><td align="left" valign="top">Snow Leopard <italic>(Panthera uncia)</italic></td><td align="center" valign="top">9</td></tr><tr><td align="left" valign="top">15</td><td align="left" valign="top">Otter <italic>(Aonyx cinereus)</italic></td><td align="center" valign="top">8</td></tr><tr><td align="left" valign="top">16</td><td align="left" valign="top">Monkey <italic>(Chlorocebus sabaeus)</italic></td><td align="center" valign="top">4</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p id="P26">List of SARS-CoV-2 genome sequences on GISAID database from various hosts, available as on 27/08/2022.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T2" position="float" orientation="portrait"><label>Table 2</label><caption><title>Deletion hotspots and their amino acid truncation</title></caption><table frame="box" rules="all"><thead><tr><th align="left" valign="top">Mutation No.</th><th align="left" valign="top">Deletion Position</th><th align="left" valign="top">ORFs</th><th align="left" valign="top">AA Deletion</th></tr></thead><tbody><tr><td align="left" valign="top"><bold>11</bold></td><td align="left" valign="top">516-518</td><td align="left" valign="top" rowspan="4" style="background-color:#ffc000"><bold>1a</bold></td><td align="left" valign="top"><bold>1a: NSP1: M85Δ</bold></td></tr><tr><td align="left" valign="top"><bold>33</bold></td><td align="left" valign="top">6506-6508</td><td align="left" valign="top"><bold>1a:T2081Δ</bold></td></tr><tr><td align="left" valign="top"><bold>35</bold></td><td align="left" valign="top">6513-6515</td><td align="left" valign="top"><bold>1a:S2083Δ</bold></td></tr><tr><td align="left" valign="top"><bold>40</bold></td><td align="left" valign="top">11288-11296</td><td align="left" valign="top"><bold>1a: NSP6: SGF 3675–3677Δ</bold></td></tr><tr><td align="left" valign="top"><bold>58</bold></td><td align="left" valign="top">21765-21770</td><td align="left" valign="top" rowspan="3" style="background-color:##c00000"><bold>S</bold></td><td align="left" valign="top"><bold>S: H69/V70 Δ</bold></td></tr><tr><td align="left" valign="top"><bold>73</bold></td><td align="left" valign="top">21992-21994</td><td align="left" valign="top"><bold>S: Y144Δ</bold></td></tr><tr><td align="left" valign="top"><bold>78</bold></td><td align="left" valign="top">22029-22034</td><td align="left" valign="top"><bold>S: EF156-157Δ</bold></td></tr><tr><td align="left" valign="top"><bold>166</bold></td><td align="left" valign="top">28248-28253</td><td align="left" valign="top" style="background-color:#f4b084"><bold>8</bold></td><td align="left" valign="top"><bold>ORF8: DF119-120Δ</bold></td></tr><tr><td align="left" valign="top"><bold>171</bold></td><td align="left" valign="top">28271</td><td align="left" valign="top"/><td align="left" valign="top"><bold>M1Δ</bold></td></tr><tr><td align="left" valign="top"><bold>174</bold></td><td align="left" valign="top">28362-28370</td><td align="left" valign="top" style="background-color:#8ea9db"><bold>N</bold></td><td align="left" valign="top"><bold>N: ENAΔ</bold></td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><p id="P27">List of deletion hotspots in the SARS-CoV-2 genome. The SARS-CoV-2 genome sequences derived from non-human hosts, available on GISAID database as on 27/08/2022.</p></fn></table-wrap-foot></table-wrap></floats-group></article>